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Abstract
Thoracic endovascular aortic repair (TEVAR) is a method of choice in the treatment of thoracic aorta aneurysms 
and dissections. In case of a thoracoabdominal aneurysm, endovascular treatment is also being chosen more 
often, especially in patients with multimorbidity. Despite better results and less invasiveness in comparison to 
classic open surgery, endovascular treatment is also associated with complications. One of the rarer and usually 
fatal complications are aortoesophageal fistula (AEF). We present two cases, in which TEVAR complication 
was AEF. Case 1 was an 87-year-old woman with a history of TEVAR 5 years earlier, who presented increased 
inflammation parameters, massive gastrointestinal bleeding, and progressive anemia. Case 2 was a 66-year-old 
woman with a history of TEVAR 6 months earlier, who on admission presented medium increased inflammatory 
markers and anemia. None of the patients was qualified for surgical treatment. Both patient 1 and patient 2 
died during hospitalization. Diagnostic imaging plays a key role in the diagnosis of AEF. CT angiography performed 
in patients with AEF can show the presence of gas in the sac of aneurysm as a result of infection, a defect in 
the aortic wall, or thickened esophagus with fluid level. CT angiography of the aorta combined with esophago-
gastroduodenoscopy (EGD) and contrast-enhanced X-ray examination of the gastrointestinal tract, enables 
to confirm or exclude the diagnosis of AEF. Atypical clinical feature and increased parameters of inflammation 
in patients with the history of TEVAR should always suggest the presence of AEF. 
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Introduction
Thoracic endovascular aortic repair (TEVAR) is a 
method of choice in the treatment of thoracic aorta 
aneurysms and dissections. In case of thoracoabdominal 
aneurysm, endovascular treatment is also being chosen 
more often, especially in patients with multimorbidity. 
Despite better results and less invasiveness in compari-
son to classical open surgery, endovascular treatment is 
also associated with complications. The most common 
complications are endoleaks to the aneurysmal sac. Rare 
complications include migration of stent graft, spinal 
cord ischemia and aortoesophageal fistula (AEF) [1]. 
We present two cases after thoracic stent graft implan-
tation. We also review the literature. 
Case report 1
87-year-old woman, who had undergone stent graft 
implantation due to thoracic aortic aneurysm, was ad-
mitted to the hospital with weakness and dehydration. 
On admission the patient was in medium condition, 
and hemodynamically stable. Laboratory test results 
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showed anemia (Hb 9,4 g/dl, RBC 3,27 × 106μl), in-
creased inflammatory markers (WBC 17,05 × 106 μl, 
CRP 143,8 mg/dl) and extremely elevated D-dimer 
(5477 ng/dl). Chest radiography showed pleural effusion 
and atelectasis of the left lung as a result of compression 
by the fluid and aortic aneurysm (Fig. 1). Antibiotics 
were implemented due to clinical, laboratory and 
auscultatory symptoms of pneumonia. During hospi-
talization, melaena and progressive anemia have been 
occurred (with the marginal level of Hb 6 g/dl). Due to 
the patient’s clinical status, the blood products were 
transfused. CT angiography of aorta showed the pres-
ence of gas in aneurysm sac, defect in the aortic wall and 
thickened esophagus with the level of fluid (Figs 2–4). 
The whole radiological feature had shown the presence 
of AEF. Oral water contrast-enhanced X-ray of the es-
ophagus revealed extraesophageal leakage of contrast, 
most likely into the aneurysmal sac (Fig. 5). EGD under 
general anesthesia was performed and demonstrated 
the presence of a wide fistula between aneurysmal sac 
and the mid-thoracic esophagus. The SEMS prosthesis 
was implanted under endoscopy control. In addition, 
control esophagus x-ray examination revealed the 
tightness of the prosthesis (Fig. 6). Open surgical repair 
of the aneurysm after the patient’s general condition 
improvement was planned. Despite the temporary 
clinical stabilization and no significant improvement, 
the patient died 13 days after admission to the hospital. 
Case report 2
66-year-old woman, who had undergone endovas-
cular treatment of the thoracoabdominal aneurysm 
using stent graft with branches to the visceral arteries 
6 months ago, was admitted to the hospital in bad gen-
eral condition. Based on the angio-CT examination, AEF 
(defect in the aortic wall and aneurysmal sac), mediast-
initis and infection of the aneurysm sac were suspected 
(Figs 7, 8). The patient had symptoms of dyspnoea, 
chest pain and fever. On admission, blood tests and 
blood culture had been taken. Blood biomarkers of 
bacterial infection were increased (procalcitonin 96 
ng/ml, CRP 328 mg/dl, WBC 12,4 × 106 μl) and blood 
culture was positive for Enterococcus species. Anti-
biotherapy and oxygen therapy had been introduced. 
Anemia was found with no decline dynamics, which 
would suggest active bleeding. Taking into considera-
Figure 1. Case report 1. Chest radiograph showing pleural 
effusion and atelectasis of left lung
Figure 2. Case report 1. Computer tomography showing the 
presence of gas in the aneurysmal sac (black arrow)
Figure 3. Case report 1. Computer tomography showing the 
presence of gas in the aneurysmal sac (black arrow)
78
Acta Angiol, 2020, Vol. 26, No. 2
www.journals.viamedica.pl/acta_angiologica
tion bad general condition and no chance of survival, 
the patient was disqualified from open surgical repair 
of the thoracoabdominal aneurysm. The patient died 
4 days after admission. 
Discussion
Aortoesophageal fistula (AEF) is a rare complication 
after TEVAR [1, 2]. In the literature, authors underline 
the great role of quick diagnostics due to difficult to 
control anemia [2, 3]. Computer tomography is an 
examination of choice in patients who had undergone 
TEVAR in case of suspected complications. In patients 
with AEF, CT angiogram shows the presence of gas in 
aneurysm sac [2, 4, 5], thickening of esophagus [6], 
and new nonhomogenous masses between aorta and 
Figure 8. Case report 2. Computer tomography showing the 
presence of gas in the aneurysmal sac (black arrow)
Figure 4. Case report 1. Computer tomography showing 
thickened esophagus with the level of fluid (black arrow)
Figure 5. Case report 1. Oral water contrast-enhanced X-ray 
examination of the esophagus showing extraesophageal leaka-
ge of contrast (black arrow)
Figure 6. Case report 1. Esophagus x-ray examination sho-
wing the tightness of the SEMS prosthesis (black arrow)
Figure 7. Case report 2. Computer tomography showing the 
presence of gas in the aneurysmal sac (black arrow)
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esophagus [2, 7]. In our cases, the presence of gas in 
aneurysm sac (Patient 1 and 2), as well as thickened 
esophagus and defect in the aortic wall (Patient 1) were 
detected. Esophagus x-ray examination with contrast 
can confirm or exclude the presence of AEF (as per 
case 1 which confirmed preliminary diagnosis based on 
CT). EGD not always identifies the place and cause of 
bleeding [5, 6]. However, in combination with CT scans, 
it significantly increases the probability of confirmation 
or exclusion of AEF [2–8]. Therefore, it seems that 
EGD should be the examination of choice when AEF 
is suspected, despite the risk of additional transmission 
of bacteria from the esophagus to the aneurysmal sac. 
The time to develop AEF after TEVAR varies. Ana-
lyzing literature, we can conclude that AEF develops 
within 1 to 16 months after the endovascular procedure 
[2–8]. Nevertheless, patient 1 developed AEF much 
later — 5 years after TEVAR. 
There are many hypotheses regarding the cause 
of AEF. Mechanisms of AEF development after TEVAR 
include: 1) pressure necrosis of the esophageal wall 
due to the ongoing forces of the self-expanding stent-
graft, 2) direct erosion of the rigid stent-graft through 
the aorta into the esophagus, 3) ischemic esophageal 
necrosis due to stent-graft occlusion of aortic side 
branches that directly feed the esophagus, 4) infection 
of stent-graft prosthesis and aneurysmal sac that even-
tually extends to the esophagus eroding its wall [7, 9]. 
Due to uncertain pathophysiologic mechanisms, we 
cannot isolate patients at high-risk, neither the time at 
which complications may occur.
Patients with AEF after TEVAR usually die before 
the beginning of treatment due to the presence of 
bleeding and general bad condition [3, 6, 8]. In these 
cases, the only option is open surgery with removal 
of the stent graft and replacement of the aorta with 
a vascular prosthesis. The majority of patients, such as 
those described in our article, do not qualify for open 
surgery [2, 5, 5]. Then, therapeutic opportunities are 
limited. Therefore, esophageal stent implantation may 
be palliative procedure [2, 5, 7]. However, this method 
doesn’t provide long-term effectiveness. There was 
the only one case of a patient with AEF free of the 
gastrointestinal bleeding reported [7]. 
Eggebrecht et al. described 6 patients who devel-
oped AEF after TEVAR. 4 of 6 patients were admitted 
to the hospital due to vomiting blood, and 2 other due 
to elevated markers of inflammation (such as patient 
1 and 2). Surgical repair was performed in only 1 patient 
and declined in the remaining because of comorbidities 
and multiorgan failure.  In 2 remaining patients who 
had undergone EGD for massive hematemesis self- 
expanding esophageal stents were implanted in order to 
control bleeding. Although conservative treatment was 
applied (percutaneous endoscopy-guided gastrostomy ― 
PEG, broad-spectrum antibiotics and proton pump 
inhibitor), all patients died due to massive bleeding 
and mediastinitis within 20-221 days after admission 
to the hospital [2].
Leung reported a 74-year-old patient with a history 
of TEVAR, who was admitted to the hospital due to 
recurrent hemoptysis. On admission, the patient wasn’t 
presenting any abnormalities in physical examination, 
nor in laboratory tests. EGD, bronchoscopy and CT 
angiography were performed. EGD detected no active 
bleeding, while bronchoscopy indicated external com-
pression of the distal trachea. CT angiogram revealed 
the presence of pseudoaneurysm of the thoracic aorta 
distal to the take-off of the subclavian artery, sug-
gesting vasculitis of the thoracic aorta. Endobronchial 
ultrasound showed aortic diverticulum in the place of 
tracheal compression. The whole radiological findings 
confirmed the presence of aortobronchial fistula (ABF). 
Therefore, it seems that the presence of the pseu-
doaneurysm, as well as compression of the airways in 
patients after TEVAR, may also suggest ABF [10]. 
During 1998–2013, Mosquera et al. [11] reviewed 26 
patients with thoracic aorta fistulas (18 with aortobron-
chial, 7 with aortoesophageal, and 1 with co-existing aor-
tic fistulas to the esophagus and bronchial tree). Authors 
were analyzing CT findings performed in all patients. The 
most common CT scan findings (in descending order of 
frequency) were: an intramural hematoma, an aortic 
pseudoaneurysm bulge, and bronchial compression. 
Interestingly, none of the patients with ABF presented 
periaortic gas. Both active contrast extravasation and the 
ectopic gas occurred exclusively in those with AEF and 
were associated with a worse prognosis. Intramural he-
matoma, an aortic pseudoaneurysm bulge and bronchial 
compression were common for those with AEF and ABF. 
All the authors underline the key role that CT plays in 
diagnosing patients with AEF and ABF. 
Conclusions 
Gastrointestinal bleeding, as well as elevated in-
flammatory markers and atypical clinical feature after 
TEVAR may suggest the presence of AEF. CT imaging 
combined with EGD and gastrointestinal X-ray exami-
nation may confirm or exclude AEF. Nevertheless, the 
ineffectiveness of treatment indicates that AEF remains 
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